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Background: Our previous study had shown that P. amaryllifolius was able to selectively inhibit cell proliferation
of hormone independent breast cancer cell line MDA-MB-231. To understand the mode of killing and mechanism
of action for P. amaryllifolius, the ethanol extract was evaluated for their alteration of cell cycle progression,
PS externalization, DNA fragmentation and expression of anti/pro-apoptotic related protein.
Results: Cell cycle progression analysis, Annexin V and Tunel assays suggested that IC50 of P. amaryllifolius ethanol
extract induced G0/G1 cell cycle arrest, PS externalization and DNA fragmentation. On the other hand, ELISA for
cytochrome c, caspase-3/7, 8 and 9 indicated that apoptosis was contributed by mitochondrial cytochrome
c release via induction of caspase 3/7, 9, and p53 was associated with the suppression of XIAP in P. amaryllifolius
treated MDA-MB-231 cells.
Conclusion: Our findings suggest that P. amaryllifolius ethanol extract induced apoptosis on hormone independent
breast cancer cell line MDA-MB-231.
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The rising prevalence of cancers and health care costs
are among propelling factors to researchers and the pub-
lic for the search of plant based systems which exert
health benefits towards reduction of cancer risks and
modification of tumor behavior. Plants have been the
basis for nearly all medicinal therapy since ancient times
until the development of synthetic drugs in the 19th
century [1]. Ample archaeological evidence indicated
that medicinal plants were regularly employed by people
in ancient cultures for biomedically curative and psy-
chotherapeutic purposes [2]. Plants have played import-
ant roles in cancer research, and indeed, most new* Correspondence: asmah@medic.upm.edu.my
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reproduction in any medium, provided the orapplications of phytochemicals over the last half century
have been for combating cancer [3]. Plant nutrients or
phytochemicals have potential as chemopreventive
agents, since most of these products are powerful anti-
oxidants [4], others are phenolic in nature and the re-
mainder includes reactive groups that confer cancer
protective properties [5].
Few plant species that provide medicinal herbs have
been scientifically evaluated for their possible medicinal
application [6,7]. A systematic search for anticancer
plants began in the middle of the 20th century through
the applications of appropriate biological screening
assays. The chemopreventive properties of plants
extracts are often investigated via screening against a
panel of human cancer cell lines [8]. Pandanus amarylli-
folius or commonly known as “daun pandan” or “pandan
wangi” is from the screw pine family. It is a commonLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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give a pleasant fresh hay like aroma [9]. Besides its aro-
matic value, P. amaryllifolius has a long history of eth-
nopharmacological uses in eleviating minor ailments
such as fever, headache, sore throat and toothache
[10,11]. Ethnomedical information reveals that the oil of
Pandanus leaves is used extensively for the treatment of
epilepsy and leprosy. This oil described as purgative,
stimulant and brings antispasmodic relief for rheumatism
conditions. In Taiwan, P. amaryllifolius is used by local
communities for its diuretic and cardiotonic properties
[10] and to cure thyroid problems and fever [11]. Previ-
ously, methanol extracts of P. amaryllifolius revealed
strong inhibitory rate toward tumor promoter 12-O-hex-
adecanoylphorbol-13- acetate (HPA)-induced Epstein-
Barr virus (EBV) activation in Raji cells [12]. Lately, P.
amaryllifolius extract was found to display selective anti-
proliferative activity against non hormone dependent
breast cancer cells [13]. Therefore, an investigation of the
chemopreventive activities of P. amaryllifolius towards
induction of apoptosis was carried out.
Methods
Preparation of the ethanol extract of Pandanus
amaryllifolius
Leaves of Pandanus amaryllifolius were collected from
Serdang, Selangor. The herbarium voucher specimen
was identified by the morphology and fragrance of the
leaves by Mr. Lim Chung Lu from the Forestry Division
of the Forest Research institute of Malaysia (FRIM
Kepong Selangor, Malaysia). The voucher number of P.
amaryllifolius is ATCL 0011. The leaves of P. amaryllifo-
lius were then thoroughly rinsed with tap and distilled
water, and were air-dried at room temperature for
2 weeks. The plant samples were later homogenized and
ground to a fine powder and soaked for 72 hr in absolute
ethanol for exhaustive solvent extraction. The extracts
were collected by filtration through Whatmann paper
No 1 and the residues were then re-soaked with a fresh
portion of ethanol twice before being subjected to evap-
oration under reduced pressure in a rotary evaporator.
The dried residues of the plant extracts were resus-
pended in DMSO (Sigma, USA) for use in biological
assays.
Cell line and cell treatment
Non-hormone dependent breast adenocarcinoma MDA-
MB-231 cell line (Cat. No. HTB-26) were obtained from
the American Type Culture Collection (ATCC, USA) and
cultured in RPMI 1640 culture medium (PAA, USA) sup-
plemented with 10% fetal calf serum (PAA, USA), and 1%
of penicillin streptomycin (PAA, USA) at 37°C, 5% CO2.
Adherent cells at 80% confluency were harvested using
Accutase (PAA, USA) for analysis.MDA-MB-231 cells were grown to the exponential
phase and treated with P. amaryllifolius ethanol extract
at a concentration that inhibited 50% of cell growth in
MTT assay (IC50 = 90 μg/mL) [13] at different time
points as stated in the following assays. Then, 1 million
of untreated control and P. amaryllifolius ethanol extract
treated MDA-MB-231 cells were harvested by Accutase
(PAA, USA), washed with cold phosphate buffer saline
(PBS) and subjected to the following test.Flow cytometry cell cycle progression quantification
After 24, 48 or 72 hr of incubation, the pelleted un-
treated and P. amaryllifolius ethanol extract treated
MDA-MB-231 cells were fixed in 80% ethanol at −20°C
for overnight. After that, the samples were washed twice
with 1 ml of PBS, resuspended in 100 μl of RNAse A
(200 μg/ml) and incubated for 30 minutes. Then, 100 μl
of propidium iodide (1 mg/ml) was added to the cells and
incubated for another 30 minutes at room temperature.
Flow cytometry was performed with a FACS Caliber (BD
Biosciences, USA).Flow cytometry Annexin V-FITC/ Propidium Iodide
analysis
Both untreated and MDA-MB-231 cells treated with P.
amaryllifolius extract for 48 hr at a concentration of
1 × 106 cells per ml were collected. The cell pellet was then
resuspended in binding buffer and stained with 5 μl of
both Annexin V FIT-C and propidium iodide using the BD
Pharmingen Apoptosis Detection Kit I (BD Biosciences,
USA) and incubated for 15 minutes. Flow cytometry was
then performed with a FACS 440 (Becton-Dickinson,
Mountain View, CA) using a 488 nm argon ion laser.
The lower left quadrant indicated viable cell, the lower
right early apoptosis and the upper right late apoptosis
population.Flow cytometry TUNEL DNA fragmentation analysis
DNA fragmentation of extract treated MDA-MB-231
cell was tested using TUNEL (terminal deoxynucleoti-
dyltransferase dUTP nick end labeling) assay (BD
Biosciences, USA). Briefly, after 48 and 72 hr of incuba-
tion, untreated and P. amaryllifolius ethanol extract
treated MDA-MB-231 cells were fixed with 1% (w/v)
paraformaldehyde in PBS for one hour followed by in-
cubating with 70% (v/v) ice cold ethanol at −20°C for
30 mins. After that, samples were washed with ice cold
PBS and added with DNA labeling reagent one hour
before adding BrdU (Bromodeoxyuridine) antibody con-
jugated with FITC (BD Biosciences, USA). Finally, the
samples were subjected to flow cytometry analysis using
FACS Caliber (BD Biosciences, USA).
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3/7, 8 and 9 detection
The release of cytochrome c to cytosol (Bender MedSys-
tems, Austria) and activation of caspase 3/7, 8 and 9
(Promega, Madison, WI) were tested using Enzyme Link
Immunosorbant Assay (ELISA). Release of cytochrome c
was tested on the control and extract treated MDA-MB-
231 cell after 12, 18 and 24 hr of incubation. On the
other hand, activation of caspase 3/7 was tested at 24, 48
and 72 hr while caspase 8 and 9 at 3, 6, 9, 12, 15, 18, 24
and 36 hr incubation times. Briefly, both untreated and
MDA-MB-231 cells treated with P. amaryllifolius etha-
nol extract at IC50 concentration at the concentration of
105 were lysed by addition of Triton-X 100 lysis buffer
from each kit. The cytochrome c, caspases 3/7, 8 or 9
present in the samples were bound to antibodies
adsorbed to the surface of the microwells. Fifty micro-
liter biotin-conjugated antihuman cytochrome c anti-
body was added to all wells prior incubation for 2 hr at
room temperature. Unbound biotin conjugated anti-
human cytochrome c antibody was removed during the
washing steps. Streptavidin-HRP was added to bind the
biotin-conjugated anti-human cytochrome c, caspases
3/7, 8 or 9 antibodies and further incubated for one
hour. Unbound Streptavidin- HRP was removed using
wash buffer and 100μl substrate solution reactive with
HRP was added to all wells. Coloured products were
formed in proportion to the amount of human cyto-
chrome c present in the cells. The reaction was termi-
nated by addition of acid and absorbance was measured
at 450 nm. The relative concentrations of cytochrome c,
caspases 8 and 9 were obtained by comparisons to their
plotted respective standard curves while the activity of
caspases 3/7 for each respective time point was expressed
as the fold change obtained using the following formula:
Fold change of caspase 3=7 ¼
 Absorbance of treatmentð
Absorbance of controlÞ=Absorbance of control
which divided the absorbance of extract treated cell to
absorbance of untreated control cell for each time point.
Flow cytometry apoptosis and cell cycle regulator protein
quantification
The collected untreated control and extract treated cells
after 24 and 48 hr of incubation were fixed and permea-
bilized using cytofix-cytoperm solution (Becton Dickin-
son, CA, USA) for flow cytometry intracellular protein
analysis. After that, the cells were stained with either
p53 (Santa Cruz, CA) or XIAP (Cat no ab26148, Abcam,
UK) primary antibodies. Then, all the cells were washed
and stained with 5 μg/10 μL of FITC goat anti-mouse Ig
(BD Biosciences, USA) secondary antibody and analysedwith FACS Caliber (BD Biosciences, USA). The results
were expressed as population of cell (%) expressing p53
and XIAP for each time point respectively.
Statistical analysis
All experiments were assayed in triplicates (n = 3). Data
were expressed as means ± S.D. All statistical analyses
were performed using Statistical Package for Social Sci-
ence (SPSS) version 15. Treatment effects were deter-
mined using one-way ANOVA post-hoc analysis. A
value of p < 0.05 was considered significant unless indi-
cated otherwise.
Results
Cell cycle progression, Annexin V/PI staining and DNA
fragmentation of P. amaryllifolius ethanol extract treated
MDA-MB-231 cells
Our previous study showed that P. amaryllifolius ethanol
extract achieved 50% of inhibition against MDA-MB-231
at a concentration of 90 μg/mL [13]. This concentration
was used in this study to confirm the mode of cell death
and the related mechanism induced by this extract. Flow
cytometry RNAse/PI staining was conducted to examine
changes in cell cycle distributions following P. amarylli-
folius ethanol extract exposure. After 24 hr, treatment of
P. amaryllifolius ethanol extract resulted in an accumula-
tion of 68% cells in G0/G1 phase (Figure 1a). This result
suggested that the growth inhibitory effect of P. amarylli-
folius ethanol extract at 24 hr was due to an arrest of
DNA replication in the cell cycle. Thus, exposure of P.
amaryllifolius ethanol extract demonstrated inhibitory
effects in cell proliferation by arresting cells in G1/G0
at 24 hr.
MDA-MB-231 cells exposed to 48 hr incubation with
PA extract resulted in detection of early apoptotic and
secondary apoptotic populations in the Annexin V/PI
study (Figure 1d). MDA-MB-231 cells exposed to 48 hr
incubation with PA extract resulted in detection of 8%
early apoptotic as well as 18% of secondary apoptotic
populations respectively while control MDA-MB-231
cells only had <5% of total apoptotic cells (Figure 1d).
Also, treatment of P. amaryllifolius extract in cell cycle
analysis, increased subG1 population in treated MDA-
MB-231 cells indicative of apoptosis (Figure 1b, 1c). At
48 hr, 12% (p < 0.05) of the treated cells were present in
subG1 peak compared with 3% of the cells in control
medium. At 72 hr, 40% (p < 0.05) of treated MDA-MB-
231 cells were detected as subG1 population. The accu-
mulation of subG1 population was directly related to the
decrease of cell populations in other phases of the cell
cycle, indicating apoptosis.
Flow cytometry TUNEL assay was carried out to con-
firm induction of apoptosis by P. amaryllifolius ethanol
extract in MDA-MB-231 cells. TUNEL-positive cells
Figure 1 Effects of P. amaryllifolius extract on MDA-MB-231 cell
DNA fragmentation. (a) P. amaryllifolius altered cell cycle
distributions (%) but not sub-G0/G1 population in treated breast
cancer MDA-MB-231 cells as compared to controls after 24 hr of
treatment in cell cycle PI study. (b),(c) P. amaryllifolius induced
subG0/G1 population of MDA-MB-231 cell after 48 and 72 hr
treatment exposure detected by cell cycle PI staining assay.
(d) P. amaryllifolius increased cell population of early and secondary
apoptosis after 48 hr of treatment in AnnexinV/PI study.
(e), (f) P. amaryllifolius induced DNA fragmentation of MDA-MB-231
cell after 48 and 72 hr treatment exposure detected by TUNEL assay.
Values are presented as means (n = 3) ± S.E. *signified (p < 0.05).
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which exposed free 3’-hydroxyl ends of double or single
stranded DNA fragments labeled with a tracer dUTP. In
TUNEL assay, after exposure of 48 hr to P. amaryllifo-
lius ethanol extract, nearly 25% of treated MDA-MB-231
cells were detected as TUNEL positive (Figure 1e, 1f ).
This percentage was similar to the secondary apoptosis
population in the Annexin V/PI study (Figure 1d) and
the subG0/G1 population in the cell cycle study of
MDA-MB-231 cells treated with extract for 48 hr. At
72 hr, nearly 45% (p < 0.05) of treated MDA-MB-231
cells were labeled as TUNEL positive cells when com-
pared to ~5% in control cells.Translocation of cytochrome c and activation of caspase
9 and effector caspase 3/7 in P. amaryllifolius ethanol
extract treated MDA-MB-231 cells
Exposure of P. amaryllifolius ethanol extract resulted in
detection of increased relative concentration of cyto-
chrome c in the cytosol of MDA-MB-231 cells. The in-
crease in cytochrome c level started after 12 hr exposure
and the peak increase (p < 0.05) was observed at 36 hr
after the exposure to P. amaryllifolius ethanol extract in
MDA-MB-231 cells (Figure 2). The concentration of
cytochrome c in control MDA-MB-231 cells remained
rather constant throughout the study period.
Increased relative concentration of initiator caspase 8
and 9 was also observed following exposure to P. amar-
yllifolius ethanol extract of MDA-MB-231 cells. Al-
though not statistically significant (p > 0.05), a steady
increase in the level of both initiator caspases was
observed after 6 hr exposure to P. amaryllifolius ethanol
extract. A larger increase in the level of intrinsic path-
way initiator caspase 9 was observed at 36 hr of expos-
ure (Figure 2). Significant one fold increment (p < 0.05)
in activity of effector caspase 3/7 was detected in MDA-
MB-231 cells at 24 and at 48 hr, more than four fold in-
crement of caspase 3/7 was noted when compared to
control cells, following exposure to P. amaryllifolius
ethanol extract (Figure 2).
Figure 2 Pandanus amaryllifolius extract induced translocation of cytochrome c into the cytosol, activation of initiator caspase 8, 9 and
effector caspase 3/7 (fold change) in treated MDA-MB-231 cells as compared to control cells. Values are presented as means (n = 3) ± S.E.
*signified (p < 0.05).
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MDA-MB-231 cells involved tumour suppressor p53
protein and apoptosis inhibitor protein XIAP
A marked increase in tumour suppressor p53 protein
level was also observed in P. amaryllifolius ethanol ex-
tract treated MDA-MB-231 cells. A significant (p < 0.05)
increase of the population of cell expressing p53 was
detected at 48 hr. Meanwhile, exposure to P. amarylli-
folius ethanol extract resulted in down regulation of
anti-apoptotic XIAP protein during 24 and 48 hr post
treatment. A significant (p < 0.05) decrease in the level
of XIAP was observed at these three incubation periods
with the largest decrease of four fold noted during 24 hr
(Figure 3).
Discussion
A previous study had reported that ethanolic extract of
P. amaryllifolius was able to selectively inhibit 50% of
cell viability on estrogen independent MDA-MB-231 but
not estrogen dependent MCF-7 breast cancer cell line
[13]. This study was aimed to understand the regulation
on cell cycle progression, mode of cell death and related
mechanism of this cytotoxic effect.
Modulations of cell cycle events and apoptosis are
amongst the modes of anti-proliferation strategies dis-
played by many natural products. Modulation of cell
cycle by P. amaryllifolius extract was evidenced by the
changes in cell cycle distributions and accumulation of
G1 population in RNAse/PI staining assayed using flow
cytometery. Individual cells in a population, can be
assigned to a cell cycle position based on DNA content,
as defined by fluorescence intensity. The proportions of
cells in the various stages of the cell cycle could there-
fore be, identified through the measurement of relative
DNA content [14]. Based on the flow cytometry analysis,
there was a reduction of cells observed in the S, G2/Mphase; and accumulation of MDA-MB-231 cells at G1
phase following exposure to P. amaryllifolius extracts at
24 hr (Figure 1a). Accumulation of cells at G1 phase
could have contributed to G1 arrest. G1 checkpoints op-
erate in the transition of G1 to S phase that restrain fur-
ther cell-cycle progression if there is incomplete DNA
replication process or sustained DNA damage. The ar-
rest in G1 allows for repair of DNA damage, thereby
avoiding the propagation of genetic lesions to progeny
cells [15].
Unlike 24 hr, P. amaryllifolius treatment for 48 and
72 hr were found to induce apoptosis on MDA-MB-231
cells. Apoptosis or programmed cell death is a distinctive
form of cell death exhibiting specific morphological and
biochemical characteristics [16]. Biochemical changes oc-
curring in mitochondria and cytoplasm during apoptosis
were assayed to portray different apoptotic cell features.
A classical feature of apoptosis, the degradation of DNA
which signifies apoptotic events at the mitochondrial
level, was also detected in breast cancer cells exposed to
P. amaryllifolius extracts. The appearance of the hypodi-
ploid sub-G0/G1 population (Figure 1c) is a specific mar-
ker of apoptosis as necrotic death did not induce sub-G1
peak in the DNA histogram [17]. On the other hand,
since strands/nicks occurrence that can be detected by
Tunel assay happens at a far higher rate in apoptosis than
necrosis, while translocation of membranne phosphati-
dylserine is an early event of apoptosis, terminal deoxy-
nucleotidyltransferase dUTP nick end labeling (TUNEL)
and Annexin V/PI assay were used to support the apop-
tosis induction by P. amaryllifolius in MDA-MB-231
cells. Translocation of membrane phospholipid phospha-
tidylserine in Annexin V/PI study (Figure 1b) and double
or single stranded DNA fragments (Figure 1c) were
detected indicating the induction of apoptosis by P.
amaryllifolius extracts in MDA-MB-231 cells [18,19].
Figure 3 P. amaryllifolius extract induced the population of MDA-MB-231 cell that expressed tumour suppressor p53 protein while
downregulated the population that expressed apoptosis inhibitor protein XIAP as compared to control cells. Values are presented
as means (n = 3) ± S.E. *signified (p < 0.05).
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apoptosis in MDA-MB-231 cells were illustrated by the
release of cellular apoptogenic factors into the cytoplasm.
To determine whether cell death induced by P. amarylli-
folius towards MDA-MB-231 cells involved intrinsic/
mitochondrial activated apoptosis pathway, detection of
cytochrome c was carried out. Mitochondrial activated
apoptosis pathway is mediated by the mitochondrial re-
lease of cytochrome c. The onset of the mitochondrial
activated apoptosis pathway is often by the occurrence of
damaged DNA not sensed or repaired by checkpoint
genes [20]. Additionally, caspases detection was per-
formed to substantiate the execution of cell death. A rise
in cytoplasm cytochrome c was detected alongside with
increase in caspases 3/7 activity. Increased in the concen-
tration of caspase 9, the caspase involved in the intrinsic
apoptosis pathway, was also noted. The study hypotheses
is that cytosolic cytochrome c induces the formation of
the multisubunit apoptosome and may trigger the activa-
tion of procaspase 9. Activated caspase 9 is cleaved later
to caspase 3, resulting in an amplifying proteolytic cas-
cade. Active caspase 3 then mediates the apoptotic cas-
cade [21]. Hence, cell death resulting from exposure of
P. amaryllifolius towards MDA-MB-231 cells was found
to involve the mitochondrial activated pathway.It has been reported that the response of the mito-
chondrial activated apoptosis pathway may or may not
be dependent on the presence of the nuclear transcrip-
tion factor, p53 at 24 hr. However, Figure 3 also sug-
gested that DNA damaging agents act to elevate p53
protein levels and/or p53-specific DNA binding activity
in cells. The mechanism of p53 induction is however un-
clear. The increases in p53 protein levels caused by
DNA-damaging agents could be triggered by a specific
DNA lesion (or by several specific DNA lesions), by any
general DNA helix distortion, or by some other signal
transduction process independent of DNA template
damage [22]. Induction of apoptosis by P. amaryllifolius
in MDA-MB-231 cells was found to be transcription-
dependent p53-mediated at 48 hr. Additionally, p53 was
also reported to accumulate on the outer surface of the
mitochondria which lead to alterations in inner mito-
chondrial transmembrane potential. Changes in the
inner mitochondrial transmembrane potential facilitate
cytochrome c release and procaspase 3 activations [23].
These observations indicated that p53 not only play a
role in transcription but it itself may direct activation of
the apoptosis machinery.
Repression of the inhibitor of apoptosis protein family
(IAPs) is another emerging strategy against cancer.
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motes cell death. Here, exposure to P. amaryllifolius had
resulted in decreased level of one of the caspase inhibi-
tor proteins, XIAP. XIAP was also shown to induce
NFκB activation, which contributes to pro-survival effect
and inflammatory stimulation [24]. Thus, a decrease in
XIAP level allows the activation of procaspase 9 and ef-
fector caspases and may have as well signaled the activa-
tion of mitogen-activated protein (MAP) Jun kinase 1
(JNK1) signal transduction pathway.
In our previous report, P. amaryllifolius was found to
contain abundantly other bioactive phytochemicals and
the phytosterol stigmasterols [25]. Several studies have
indicated that certain types of phytosterols may possess
anticancer activity. The cytotoxicity of stigmasterol
against cancer cells evidenced towards breast cancer cells
[26]. Cytotoxicity of other plant sterols was also observed
towards colon cancer cells [27,28]. Stigmasterols or gen-
erally phytosterols were hypothesized to exert their antic-
ancer properties through multiple pathways inclusive of
modulations of signal transduction pathways and apop-
tosis. Phytosterols were found to inhibit tumor growth of
non-hormone dependent breast cancer cells via the
sphingomyelin pathway. Stigmasterol was reported to in-
duce four to six fold increases in apoptotic death in
MDA-MB-231 cells as evidenced by measuring the re-
lease of nucleosomes into the cytoplasm. The molecular
targets in apoptosis induction by stigmasterols were
found to involve down regulation of oncogene c-myc and
transcription factor p53. These bioactive compounds
present in P. amaryllifolius extracts work synergistically
in inhibiting proliferation of breast cancer cells. Stigmas-
terols as one component of P. amaryllifolius extracts
may have contributed to the induction of the p53
mediated apoptosis pathways in MDA-MB-231 cells.Conclusion
Ethanol extracts of P. amaryllifolius mediated mitochon-
drial activated apoptosis pathways in MDA-MB-231 cells.
The molecular mechanisms in the induction of apoptosis
by P. amaryllifolius and its bioactive components were
found to involve upregulation of the tumour suppressor
protein p53 and a reduction in the inhibitor of apoptosis
protein XIAP. However, XIAP is not the only member of
IAP family that involve in anti-apoptotic effect and the
involvement of extrinsic apoptosis pathway to induce this
mitochondrial activated apoptosis pathway is still un-
known. Thus, further studies including isolation of indi-
vidual stigmasterols and confirmation of both intrinsic
and extrinsic apoptosis mediated by the isolated stigmas-
terols should be the direction to confirm the role of stig-
masterols in the cytotoxicity effect of P. amaryllifolius
ethanolic extract against MDA-MB-231 cell.Competing interests
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